Natural Product: NPC549862

Natural Product IDNPC549862
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
2-(3,4-dimethoxyphenyl)-5-methoxy-7-[(2~{S},3~{S},4~{S},5~{S},6~{R})-3,4,5-trihydroxy-6-[[(2~{S},3~{R},4~{R},5~{R})-3,4,5-trihydroxytetrahydropyran-2-yl]oxymethyl]tetrahydropyran-2-yl]oxy-chromen-4-one
IUPAC Name 2-(3,4-dimethoxyphenyl)-5-methoxy-7-[(2~{S},3~{S},4~{S},5~{S},6~{R})-3,4,5-trihydroxy-6-[[(2~{S},3~{R},4~{R},5~{R})-3,4,5-trihydroxytetrahydropyran-2-yl]oxymethyl]tetrahydropyran-2-yl]oxy-chromen-4-one
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier n.a.
PubChem CID n.a.
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey SIWCLUVDCVTJDC-GETFLKSSSA-N
Standard InCHI InChI=1S/C29H34O15/c1-37-16-5-4-12(6-18(16)38-2)17-9-14(30)22-19(39-3)7-13(8-20(22)43-17)42-29-27(36)25(34)24(33)21(44-29)11-41-28-26(35)23(32)15(31)10-40-28/h4-9,15,21,23-29,31-36H,10-11H2,1-3H3/t15-,21-,23-,24-,25+,26-,27+,28+,29-/m1/s1
SMILES COC1=CC=C(C2=CC(=O)C3=C(OC)C=C(O[C@@H]4O[C@H](CO[C@@H]5OC[C@@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@@H]4O)C=C3O2)C=C1OC

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   622.19 Volume:   578.119
?
Van der Waals volume.
Dense:   1.076 LogP:   0.825
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   1.262
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -2.844
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   9.0 Rigid Bonds:   30.0
TPSA:   216.2
?
Topological Polar Surface Area.
H-Bond Acceptor:   15.0
H-Bond Donor:   6.0 Rings:   5.0
Heavy Atoms:   15.0

MedChem Properties

QED Drug-Likeness Score:   0.171 GASA:   0.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   4.565 Fsp3:   0.483
MCE-18:   114.349
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Accepted
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Accepted BMS Rule:   0
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.623 Fluc inhibitor:   0.262
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.895
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.646
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.031 Promiscuous compounds:   0.187

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -6.059 MDCK Permeability:   -5.253
Pgp-inhibitor:   0.001 Pgp-substrate:   0.976
PAMPA:   0.996
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.977
20% Bioavailability (F20%):   0.758 30% Bioavailability (F30%):   0.981
50% Bioavailability (F50%):   0.998

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.0 MRP1:   0.564
Plasma Protein Binding (PPB):   78.832% Volume Distribution (VD):   -0.221
Fu: 18.879%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.996
OATP1B3 inhibitor:   1.0 BCRP inhibitor:   0.891
BSEP inhibitor:   0.346

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   0.0
CYP2C19-inhibitor:   0.0 CYP2C19-substrate:   0.0
CYP2C9-inhibitor:   0.0 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.0 CYP2D6-substrate:   0.0
CYP3A4-inhibitor:   0.0 CYP3A4-substrate:   0.003
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.089
HLM stability:   0.0
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  1.622 Half-life (T1/2):  4.213

ADMET: Toxicity

hERG Blockers:  0.024 hERG Blockers (10um):  0.103
Human Hepatotoxicity (H-HT):  0.361 Drug-induced Liver Injury (DILI):  0.829
AMES Toxicity:  0.886 Rat Oral Acute Toxicity:  0.013
Maximum Recommended Daily Dose:  0.059 Skin Sensitization:  0.981
Carcinogencity:  0.125 Eye Corrosion:  0.0
Eye Irritation:  0.146 Respiratory Toxicity:  0.019
Drug-induced Neurotoxicity:  0.007 Ototoxicity:  0.948
Hematotoxicity:  0.549 Drug-induced Nephrotoxicity:  0.716
Genotoxicity:  0.131 RPMI-8226 Immunitoxicity:  0.231
A549 Cytotoxicity:  0.329 Hek293 Cytotoxicity:  0.394
BCF:   0.196
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   2.925
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   4.413
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   3.599
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO23424 Dirca palustris Species Thymelaeaceae Eukaryota n.a. n.a. n.a. PMID[10579873]
NPO23424 Dirca palustris Species Thymelaeaceae Eukaryota n.a. n.a. n.a. PMID[26225905]
NPO23424 Dirca palustris Species Thymelaeaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO23424 Dirca palustris Species Thymelaeaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC549862 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC475497
0.95 High Similarity NPC284277
0.8765 High Similarity NPC473657
0.8571 High Similarity NPC475366
0.8313 Intermediate Similarity NPC295613
0.8214 Intermediate Similarity NPC15358
0.8118 Intermediate Similarity NPC473512
0.7701 Intermediate Similarity NPC129827
0.686 Remote Similarity NPC182045
0.6087 Remote Similarity NPC293004
0.5957 Remote Similarity NPC52353
0.5824 Remote Similarity NPC610763
0.5778 Remote Similarity NPC110349
0.5714 Remote Similarity NPC22062
0.5714 Remote Similarity NPC473634
0.5714 Remote Similarity NPC138811
0.5696 Remote Similarity NPC70853
0.5684 Remote Similarity NPC194483
0.567 Remote Similarity NPC51774
0.5657 Remote Similarity NPC204693
0.551 Remote Similarity NPC236191
0.549 Remote Similarity NPC483707
0.549 Remote Similarity NPC209296
0.5474 Remote Similarity NPC243930
0.5474 Remote Similarity NPC284960
0.5455 Remote Similarity NPC301683
0.5437 Remote Similarity NPC488089
0.5417 Remote Similarity NPC607707
0.5385 Remote Similarity NPC231194
0.5377 Remote Similarity NPC244875
0.534 Remote Similarity NPC473623
0.534 Remote Similarity NPC51326
0.5306 Remote Similarity NPC211594
0.53 Remote Similarity NPC44931
0.53 Remote Similarity NPC142996
0.5248 Remote Similarity NPC210073
0.5152 Remote Similarity NPC172807
0.5146 Remote Similarity NPC488074
0.51 Remote Similarity NPC254540
0.5096 Remote Similarity NPC65711
0.5052 Remote Similarity NPC609451
0.5051 Remote Similarity NPC61791
0.5047 Remote Similarity NPC101636

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC549862 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.6566 Remote Similarity NPD7472 Pre-clinical
0.549 Remote Similarity NPD7054 Phase 4
0.5056 Remote Similarity NPD3817 Phase 3
0.5046 Remote Similarity NPD7808 Phase 3

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data